A preliminary study on the promotion of wound healing by paeoniflorin carbon dots loaded in chitosan hydrogel
Biomedical Materials · 2025
DOI: 10.1088/1748-605x/add2ba ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials, 2025. Verfasst von Ruiming Feng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Medical University School and Hospital of Stomatology, Taiyuan 030001, Shanxi, People's Republic of China. Hauptthemen laut MEDLINE: Wound Healing, Chitosan, Glucosides, Carbon. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Gefördert von: Science and Technology Innovation Leader and Key Talent Team Project of Shanxi Province, Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi, Shanxi Provincial Basic Research Program.
Themen: Wundversorgung
Abstract (Originalsprache)
Due to poor angiogenesis under the wound bed, wound treatment remains a clinical challenge. Therefore, there is an urgent need for new dressings to combat bacterial infections, accelerate angiogenesis, and accelerate wound healing. In this study, we prepared carbon dots nanomaterial (PF-CDs) derived from traditional Chinese medicine paeoniflorin using a simple green one pot hydrothermal method. The average particle size of the CSs we prepared was 4 nm, and a concentration of 200 μg ml −1 was ultimately selected for experiments. Subsequently, PF-CDs were loaded into the chitosan hydrogel to form a new type of wound dressing CSMA@PF-CDs hydrogel. CSMA@PF-CDs demonstrated positive biocompatibility by promoting a 20% increase in cell proliferation and strong antibacterial activity. In comparison to the control group, CSMA@PF-CDs enhanced the expression level of anti-inflammatory factors by at least 2.5 times and reduces the expression level of pro-inflammatory factors by at least 3 times. Furthermore, CSMA@PF-CDs promoted the migration of Human umbilical vein endothelial cells and increased vascular endothelial growth factor expression by 5 times. The results of in vivo experiments indicate that CSMA@PF-CDs significantly promoted the healing of back wounds in rats. These characteristics make it a promising material for repairing infected wounds and a potential candidate for clinical skin regeneration applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Medical University School and Hospital of Stomatology, Taiyuan 030001, Shanxi, People's Republic of China.
- Shanxi Province Key Laboratory of Oral Diseases Prevention and New Materials, Taiyuan 030001, Shanxi, People's Republic of China.
- Laboratory for Oral and General Health Integration and Translation, Beijing Tian tan Hospital, Capital Medical University, Beijing 100069, People's Republic of China.
ORCID-Profile: Bing Li
Förderung
- Science and Technology Innovation Leader and Key Talent Team Project of Shanxi Province
- Scientific and Technologial Innovation Programs of Higher Education Institutions in Shanxi
- Shanxi Provincial Basic Research Program
- Research Project Supported by Shanxi Scholarship Council of China
Zitieren
APA
Feng, R., Tian, F., Zhou, J., Ping, Y., Han, W., Shi, X., Bai, X., Sun, Y., Zhao, J., Wu, X., & Li, B. (2025). A preliminary study on the promotion of wound healing by paeoniflorin carbon dots loaded in chitosan hydrogel. Biomedical Materials. https://doi.org/10.1088/1748-605x/add2ba
Vancouver
Feng R, Tian F, Zhou J, Ping Y, Han W, Shi X, et al. A preliminary study on the promotion of wound healing by paeoniflorin carbon dots loaded in chitosan hydrogel. Biomedical Materials. 2025. doi:10.1088/1748-605x/add2ba
BibTeX
@article{Feng2025,
author = {Feng, Ruiming and Tian, Feng and Zhou, Jian and Ping, Yilin and Han, Wenze and Shi, Xuexue and Bai, Xue and Sun, Yufeng and Zhao, Jiali and Wu, Xiuping and Li, Bing},
title = {A preliminary study on the promotion of wound healing by paeoniflorin carbon dots loaded in chitosan hydrogel},
journal = {Biomedical Materials},
year = {2025},
doi = {10.1088/1748-605x/add2ba}
}
EUVIMED